190 related articles for article (PubMed ID: 37466830)
1. Treatment with Antiobesity Drugs in Weight Regain After Bariatric Surgery: a Retrospective Cohort Study.
Boger BS; Queiroz NL; Noriega PEP; Canuto MC; Stumpf MAM; Cercato C; Mancini MC; de Melo ME
Obes Surg; 2023 Sep; 33(9):2941-2944. PubMed ID: 37466830
[TBL] [Abstract][Full Text] [Related]
2. Utilization of Anti-obesity Medications After Bariatric Surgery: Analysis of a Large National Database.
Firkins SA; Chittajallu V; Flora B; Yoo H; Simons-Linares R
Obes Surg; 2024 May; 34(5):1415-1424. PubMed ID: 38512645
[TBL] [Abstract][Full Text] [Related]
3. The utility of weight loss medications after bariatric surgery for weight regain or inadequate weight loss: A multi-center study.
Stanford FC; Alfaris N; Gomez G; Ricks ET; Shukla AP; Corey KE; Pratt JS; Pomp A; Rubino F; Aronne LJ
Surg Obes Relat Dis; 2017 Mar; 13(3):491-500. PubMed ID: 27986587
[TBL] [Abstract][Full Text] [Related]
4. High Prevalence of Positive Genetic Obesity Variants in Postoperative Bariatric Surgery Patients with Weight Regain Presenting for Medical Obesity Intervention.
Samuels JM; Paddu NU; Rekulapeli A; Madhar A; Srivastava G
Obes Surg; 2024 Jan; 34(1):170-175. PubMed ID: 37996769
[TBL] [Abstract][Full Text] [Related]
5. Use of Weight Loss Medications in Patients after Bariatric Surgery.
Redmond IP; Shukla AP; Aronne LJ
Curr Obes Rep; 2021 Jun; 10(2):81-89. PubMed ID: 33492629
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic management of weight regain following bariatric surgery.
Lucas E; Simmons O; Tchang B; Aronne L
Front Endocrinol (Lausanne); 2022; 13():1043595. PubMed ID: 36699042
[TBL] [Abstract][Full Text] [Related]
7. Comparison of orlistat and sibutramine in an obesity management program: efficacy, compliance, and weight regain after noncompliance.
Gursoy A; Erdogan MF; Cin MO; Cesur M; Baskal N
Eat Weight Disord; 2006 Dec; 11(4):e127-32. PubMed ID: 17272944
[TBL] [Abstract][Full Text] [Related]
8. A Specialized Medical Management Program to Address Post-operative Weight Regain in Bariatric Patients.
Srivastava G; Buffington C
Obes Surg; 2018 Aug; 28(8):2241-2246. PubMed ID: 29464536
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of weight-reducing drugs in people with hypertension.
Siebenhofer A; Jeitler K; Horvath K; Berghold A; Posch N; Meschik J; Semlitsch T
Cochrane Database Syst Rev; 2016 Mar; 3():CD007654. PubMed ID: 26934640
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Post-bariatric Abdominoplasty on Secondary Weight Regain After Roux-en-Y Gastric Bypass.
Sandvik J; Hole T; Klöckner C; Kulseng B; Wibe A
Front Endocrinol (Lausanne); 2020; 11():459. PubMed ID: 32849265
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of weight-reducing drugs in people with hypertension.
Siebenhofer A; Winterholer S; Jeitler K; Horvath K; Berghold A; Krenn C; Semlitsch T
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD007654. PubMed ID: 33454957
[TBL] [Abstract][Full Text] [Related]
12. Revisional Surgery or Pharmacotherapy for Insufficient Weight Loss and Weight Regain After Primary Bariatric Procedure: a Descriptive Study.
Dharmaratnam VM; Lim E; Eng A; Chan WH; Tan HC; Ho E; Kovalik JP; Ganguly S; Tan J; Lee PC; Lim CH
Obes Surg; 2022 Oct; 32(10):3298-3304. PubMed ID: 35994181
[TBL] [Abstract][Full Text] [Related]
13. Combining transoral outlet reduction with pharmacotherapy yields similar 1-year efficacy with improved safety compared with surgical revision for weight regain after Roux-en-Y gastric bypass (with videos).
Jirapinyo P; Thompson CC
Gastrointest Endosc; 2023 Oct; 98(4):552-558. PubMed ID: 37150416
[TBL] [Abstract][Full Text] [Related]
14. The Mitigating Effect of Phentermine and Topiramate on Weight Regain After Roux-en-Y Gastric Bypass Surgery.
Istfan NW; Anderson WA; Hess DT; Yu L; Carmine B; Apovian CM
Obesity (Silver Spring); 2020 Jun; 28(6):1023-1030. PubMed ID: 32441476
[TBL] [Abstract][Full Text] [Related]
15. Cost-Effectiveness of Antiobesity Drugs for Adolescents With Severe Obesity.
Mital S; Nguyen HV
JAMA Netw Open; 2023 Oct; 6(10):e2336400. PubMed ID: 37824146
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of adjuvant weight loss medication after bariatric surgery.
Nor Hanipah Z; Nasr EC; Bucak E; Schauer PR; Aminian A; Brethauer SA; Cetin D
Surg Obes Relat Dis; 2018 Jan; 14(1):93-98. PubMed ID: 29287757
[TBL] [Abstract][Full Text] [Related]
17. Behavioral predictors of weight regain after bariatric surgery.
Odom J; Zalesin KC; Washington TL; Miller WW; Hakmeh B; Zaremba DL; Altattan M; Balasubramaniam M; Gibbs DS; Krause KR; Chengelis DL; Franklin BA; McCullough PA
Obes Surg; 2010 Mar; 20(3):349-56. PubMed ID: 19554382
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant and Neo-Adjuvant Anti-Obesity Medications and Bariatric Surgery: A Scoping Review.
Sher T; McGee M; DuCoin C; Sujka J; Docimo S
Curr Obes Rep; 2024 Jun; 13(2):377-402. PubMed ID: 38507194
[TBL] [Abstract][Full Text] [Related]
19. Risk of de-novo inflammatory bowel disease among obese patients treated with bariatric surgery or weight loss medications.
Kochhar GS; Desai A; Syed A; Grover A; El Hachem S; Abdul-Baki H; Chintamaneni P; Aoun E; Kanna S; Sandhu DS; Singh S; Shen B; Loftus EV; Dulai PS
Aliment Pharmacol Ther; 2020 Jun; 51(11):1067-1075. PubMed ID: 32319111
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacological therapy of obesity].
Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
